and you will have your shares at a 20% discount to what Bruce last paid in April.
The share price here is irrelevant - it's low. Maybe it goes lower - who cares? When the masses come back again, the shares will go higher - much higher. As news begins to flow, shares will go higher.
For months people were posting here how the shares weren't going higher because there wasn't a CEO installed. Now there is - you got what you want. Now, just because the shares didn't go up immediately, everything has changed? Maybe it was a small case of buy on the rumor, sell on the news? Now that there's a CEO, what's to look forward to?
If you have no patience, as others have said - sell and move along.
The entire market is weak currently - SNTA shares are not really performing much differently from most other small caps and biotechs at this time. Further, being the latter part of September, certainly end of quarter window dressing is taking place.
The investment thesis has not changed. You will not see Bruce/Caxton selling shares. If anything, we may see him soon hand over another $5 million to the company to get more shares at the current price level.
I previously mentioned my thoughts, yesterday I saw my vision on the shelf at Walgreens.
Go and google for AllergEase.
There it is - the solution to our problem.
Executed better than expected for the quarter. Decent outlook. Next quarter has losses lower than current estimate. CEO is very strong and has the right plan for moving forward.
This is a turnaround play - it's expected that there would be a few soft quarters. The company is doing what's necessary to return to long-term growth/profitability.
Book to bill 1.26
The way to play these is by buying slowly on the way down - don't shoot your wad all at once or you will be extremely disappointed if you don't catch the absolute bottom.
He would buy directly through SNTA because it's real easy to have a single transaction at a fixed price as opposed to buying 1.5 million shares in the open market over an extended period and moving the price with your purchases.
I assure you, short-term technical games like a short squeeze is not his objective. More folks would just short at higher prices. What is going to drive the shares higher are results - we know thus far the results are good and very promising. As we get further down the road, more trial/study results will be coming in, and that is what is going to drive the shares higher and provide strong support going forward.
Earnings and press release speak for themselves.
Red ink to flow, lots more shares to be issued and thus dilution. More legal fees coming.
Thanks for the gains/profits over the past year Ted - I really appreciate it, but I'm not going along for this ride with you.
Good luck to all who stay - I wish you nothing but success with this investment and all others.
"Sidoti seems to be giving us a warning about possible lower prices. Others here may disagree and dislike the fact that I'm mentioning it but just by reviewing their web site, they seem to be under no pressure to do anything but provide research. "
What happened is perfectly clear. Sidoti did nothing but read the headline and shoot from the hip, plain and simple. If you give credence to that type of "coverage", then more power to you. What I've learned is that it's the kind of stuff that shock journalism is made of. I think back to when another big firm put a similar type of rating on Royal Caribbean Cruise Lines when it was trading at $5 not so many years ago. The company and stock price performance since that day speaks for itself.
So, if you look to such dramatization from the only firm providing coverage, that they provided absolutely no details of specifics why they issued their downgrade and price target before having any details from the company, then again, soak it all in.
You will see Sidoti move back to a buy rating with the prior $2 price target they had when the company finalizes and submits the filings - with absolutely no material changes having taken place during the period. I will bank on it.
Director who only held a small number of shares to begin with.
If Popielec, Fain, or Whitmore/Sunray sell shares I might be more interested.
bambino - sorry for the delay getting back to you on this.
yes, the cash conversion cycle is obviously directly related to the inventory. Phil explained this on the conference call and indicated they are going to be on top of it to get it down...
Philip A. Fain
No, it’s certainly can’t be Gary. The situation that we are currently in is the – the timing between receiving an order and shifting an order based on some of the items that are backlogged in contracting for comms systems has caused our inventory to creep up a just a little bit over the end of last year, but our target is going forward is not to carry $27 million of inventory – is to bring that down rather significantly.
The reasons they bought at $2950 is because:
1. If they had bought back in the open market, it would have taken forever to do it
2. Had they wanted to buy that many shares relatively quicky they would have driven the price up much higher than that
3. They believed that $2950 was a fair value at the time
Market obviously agreed with the logic as the company were only able to tender about half of what they were prepared to buy and shares then went up past $3100 afterwards.
As far as the remainder of your post - right on - plainly obvious to everyone that's here...now, the rest of the market should be able to understand such obvious things.
I don't think the price matters all that much at this time...other than some people are going to lose real money by selling, and I'm going to get the opportunity to acquire more shares at lower prices before the game is halted. I'm quite confident that this will all come to an abrupt halt one way or another - just a matter of when it happens - could be a couple days, a couple weeks, or a couple months, but I am certain that based on the information we/you have, we are getting close to the end of it.
"If we double 6 month revenues we'll have about $61 million for the year, 2% to 3% would be operating loss of about $1.5 million and currently we are at a loss of $2.4 million..."
As indicated on the call, back half is expected to be about $40 million revenues and about $70 million total for the year. So, 2% to 3% is a loss of about $1.75 million - again, there will be profitability the remainder of the year. As also indicated, this is the conservative view. They are successfully diversifying into commercial areas to compensate for decline in government business. When government business comes, it will be icing on the cake.
Now is the time to be buying these small banks during the summer doldrums (for banking stocks). This happens most every year. However, this year it is even more a time to be buying them in a big way. Interest rates will trend higher next year, and when that (finally) happens bank earnings increase! Most people are looking the other way and do not understand these basic concepts.
In the mean time, slowly acquire shares if the trend lower. Diversify across multiple names. Look more towars book value and those trading near or below compared to those wildly above book value. Make exceptions for those carrying low debt loads, growing top/bottom line, and paying good/stable/increasing dividends. Lastly, those that are potential acquisition targets (like AROW) should be on the top of the list for accumulation.
Yes, I saw that - I'm suspecting they may post a small loss for the quarter...probably will take some one time charges for closing the two branch locations and probably some for acquisition and beginning of Slavie integration.
they are doing fine. read the announcement closely.
"As a result of the revised outlook for revenue, management now expects a slight operating loss for the year in the range of 2 -- 3% of sales."
If we double 6 month revenues we'll have about $61 million for the year, 2% to 3% would be operating loss of about $1.5 million and currently we are at a loss of $2.4 million - implication is that for the remainder of the year we'll see an operating profit of about $1 million. This is important - as also indicated in the announcement, margins are improving and outlook is better. Sales of new products are slowly rising, and eventually government sales will come back - when they do, the company will be solidly profitable.
Yes, it is difficult playing the waiting game, however, overall operationally things are getting much better as we move forward. The balance sheet is still solid and improving.
What did I say?
It is really amazing the level of transparency of the corruption that goes on. Initiate coverage, give a buy rating, give an upgrade...and we'll give you our business.
Way to go Ivan!
Stay away from this smelly garbage.
"Deutsche Bank Securities Inc., Keefe, Bruyette & Woods, Inc. and MLV & Co. LLC are serving as joint book-running managers for the offering."